2413-4341

2413-4341

S2413-43412020000100005

10.18004/rpr/2020.06.01.5-10

Paraguay

00 06 2020

00 06 2020

6 1 5 10

1

2018 39 1 1

1-12

2

2010 36 1 1

53-80

3

2011 20 11 11

1187-92

4

2008 152 4 4

550-6

5

2012 5

476-505

6

2014 99 6 6

563-7

7

2012 59 2 2

345-64

8

1998 10

399-408

9

2018 47

37-43

10

2010 37 3 3

45-57

11

2010 37 3 3

18-29

12

2016 15

118-204

13

2010 19 12 12

1414-8

14

2017 26 4 4

426-30

15

2012 21 8 8

878-84

16

2015 37 4 4

230-5

17

2015 31 1 1

68-70

18

2016 63 7 7

1238-43

19

2012 64 8 8

2677-86

20

for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology 1997 40

1725

21

2019 71 9 9

1400-12

22

2007 16

550-5

23

2016 68 11 11

1736-41

24

UK JSLE Study Group 2016 25 14 14

1542-50

25

2012 10 1 1

12

26

2018 37 12 12

3299-307

27

2008 17

596-604

28

2016 14 1 1

94-109

29

2013 12 7 7

784-91

30

2004 83 1 1

1-17

31

2015 3

79

32

2018 9

171-84

33

2004 24 40-2 40-2